November 15, 2018 / 7:22 AM / a month ago

Novartis preparing to split off Sandoz generics unit - Tages-Anzeiger

ZURICH, Nov 15 (Reuters) - Swiss drugmaker Novartis is preparing to split off its Sandoz generics unit, Swiss newspaper Tages-Anzeiger reported on Thursday, citing an employee representative.

“Sandoz will be split off, that is the informal information that we have gotten,” the employee representative said, the Tages-Anzeiger reported.

A Novartis spokesman called the newspaper report “speculation”, in response to an inquiry from Reuters. (Reporting by John Miller; Editing by Adrian Croft)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below